Since its inception in 2016, the fund has achieved the following 
  • 48% of eligible Quad faculty applied
  • Reviewed 158 grant proposals
  • Q-FASTR awardees had 5 new start-up companies and over $160 million in follow-on funding

2024 Request for Proposals

Release date: Tuesday, December 12, 2023

Pre-proposal due: Wednesday, February 7, 2024

Full proposal due: Tuesday, April 30, 2024

Funding start date: Monday, July 1, 2024

2023 Awardees

Congratulations to the following award recipients of the 2023 Q-FASTR RFP:

  • David Corey (Harvard Medical School) and Benjamin Kleinstiver (Harvard Medical School/Massachusetts General Hospital)
  • Peter Howley (Harvard Medical School)
  • Andrew Kruse (Harvard Medical School) and Daniel Kahne (Harvard University)
  • Mark Namchuk (Harvard Medical School), Alfred Goldberg (Harvard Medical School), David Fisher (Harvard Medical School/Massachusetts General Hospital) and Galen Collins (Mississippi State University)
  • Peter Sorger (Harvard Medical School) and Sandro Santagata (Harvard Medical School/Brigham and Women’s Hospital)
  • George Church (Harvard Medical School)
  • Marco Jost (Harvard Medical School)
  • Allon Klein (Harvard Medical School)
  • Arlene Sharpe (Harvard Medical School)
  • Ulrich von Andrian (Harvard Medical School)
  • Amy Wagers (Harvard University)

For more details about their research, please visit the Projects section.

2023 Q-FASTR Poster Showcase & Reception

Q-FASTR is dedicated to transforming cutting-edge basic research at HMS into tomorrow’s therapeutics, diagnostics, and related technologies. By championing early ideas and enveloping them with financial and scientific support, we cultivate breakthroughs that have the potential to reshape medicine.

Ifat Rubin-Bejerano
Senior Director, Translational Research Programs, Harvard Medical School